• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Nicholas (Nic) Bowman, South Africa

      Nicholas (Nic) Bowman, South Africa

    • Richard Clark, New Zealand

      Richard Clark, New Zealand

    • Shay Rishoni, Netherlands

      Shay Rishoni, Netherlands

    • Ana Lilia Rodriguez, Mexico

      Ana Lilia Rodriguez, Mexico

    • Mahmood Anwar, UK

      Mahmood Anwar, UK

    • Margarita Pizarro, Argentina

      Margarita Pizarro, Argentina

    • Steve

      Steve

    • Seckin McGuirk, England

      Seckin McGuirk, England

    • Lombana, Spain

      Lombana, Spain

    • Torben Mikkelsen, Denmark

      Torben Mikkelsen, Denmark

    • Ali Var, Turkey

      Ali Var, Turkey

    • Andrea Zicchieri, Italy

      Andrea Zicchieri, Italy
      AndreaZicchieri_conSLAncioItaly

    • Hans Dieter Olszewski, Germany

      Hans Dieter Olszewski, Germany

    • Joanne Pratt, Australia

      Joanne Pratt, Australia

    • Aida Trzmiel de Guterman, Argentina

      Aida Trzmiel de Guterman, Argentina

    • Luis Antonio Pimenta Lima, Brazil

      Luis Antonio Pimenta Lima, Brazil

    • Irene McCaughey, Australia

      Irene McCaughey, Australia

    • Stephanie Christiansen Hall, Canada

      Stephanie Christiansen Hall, Canada

    • Carlos Gomez Matallanas, Spain

      Carlos Gomez Matallanas, Spain

    • Frank Taylor, USA

      Frank Taylor, USA

    • Wendy Hendrickson, USA

      Wendy Hendrickson, USA

    • Ian Gale, Australia

      Ian Gale, Australia

    • Chih Ching Darren Wong, Malaysia

      Chih Ching Darren Wong, Malaysia

    • Ana María Zavala, Mexico

      Ana María Zavala, Mexico

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Angie Bordaen, Belgium

      Angie Bordaen, Belgium

    • Inta Grubb, Australia

      Inta Grubb, Australia

    • Ailsa Malcolm-Hutton, UK

      Ailsa Malcolm-Hutton, UK

    • Mike Cels, Canada

      Mike Cels, Canada

    • Roy Taylor, Ireland

      Roy Taylor, Ireland
      roy

    • Xian-Zhang Niu, China

      Xian-Zhang Niu, China

    • Cassio Fernando da Silva, Brazil

      Cassio Fernando da Silva, Brazil

    • Colm Francis Davis, Ireland

      Colm Francis Davis, Ireland

    • Laurie Petit-Jean, France

      Laurie Petit-Jean, France

    • Catherine Pearce, Australia

      Catherine Pearce, Australia

    • Erwin Coppejans, Belgium

      Erwin Coppejans, Belgium

    • Sébastien Batiot, France

      Sébastien Batiot, France

    • Liong Ting Ngu, Malaysia

      Liong Ting Ngu, Malaysia

    • Mikey Stone, ALS

      Mikey Stone, ALS

    • Jay Epstein, USA

      Jay Epstein, USA

    • Wiebke Braach, Germany

      Wiebke Braach, Germany

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Jorge Melo, Brazil

      Jorge Melo, Brazil

    • Shera Mukherjee, India

      Shera Mukherjee, India

    • Dick Dayton, USA

      Dick Dayton, USA

    • Dan Doctoroff, USA

      Dan Doctoroff, USA

    • Zelina Brito, Brazil

      Zelina Brito, Brazil

    • Rolf Mauch, Switzerland

      Rolf Mauch, Switzerland

    • Hanne Stenmose, Denmark

      Hanne Stenmose, Denmark

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login